Zengeza Clinical Research Site
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mgodi, Nyaradzo
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Recruiting
3
3500
RoW
CAB LA, Apretude, CAB LA for PrEP
ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP
HIV Infections
06/28
06/28
CoVPN3008, NCT05168813: Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

Completed
2/3
14232
RoW
Moderna mRNA-1273, Vaccine 3 Dose, Vaccine 2 Dose
COVID-19 Prevention Network, National Institute of Allergy and Infectious Diseases (NIAID), Medical Research Council, South Africa
SARS-CoV-2 Infection, HIV Infections, COVID-19
04/24
04/24
NCT05458765: Project Engage: Oral PrEP Acceptability

Completed
2
330
RoW
emtricitabine/tenofovir alafenamide, Descovy, Emtricitabine / Tenofovir Disoproxil Oral Tablet, Truvada
Eastern Virginia Medical School, CONRAD, FHI 360, United States Agency for International Development (USAID), Gilead Sciences
Acceptability of Health Care, Adherence, Medication
12/23
07/24
MATRIX-003, NCT06163274: Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Rings

Terminated
1
93
US, RoW
Placebo Intravaginal Ring A, Placebo Intravaginal Ring B
University of Pittsburgh, United States Agency for International Development (USAID), Oak Crest Institute of Science
Safety, Acceptability
01/25
01/25
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films

Completed
1
100
US, RoW
Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners
Rohan, Lisa, PhD, United States Agency for International Development (USAID)
Safety, Acceptability, Usability
12/24
12/24
INSIGHT, NCT05746065: A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women

Completed
N/A
3087
RoW
PrEP, Truvada
University of Washington, Bill and Melinda Gates Foundation
HIV Infections
08/23
08/23
NCT04778514: A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

Completed
N/A
30
RoW
Dual Prevention Pill, DPP, PrEP and combined oral contraceptive (COC) as two separate tablets, Truvada, Zinnia F
Population Council, University of Zimbabwe
HIV Infections, Contraception
09/23
09/23
CoVPN3008TB, NCT06585683: Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008

Recruiting
N/A
6000
RoW
Clinical Evaluation at Day 4, Laboratory Evaluation at Day 4, Clinical Evaluation at week 26, Laboratory Evaluation at week 26
COVID-19 Prevention Network, National Institute of Allergy and Infectious Diseases (NIAID), Medical Research Council, South Africa
Tuberculosis
10/25
10/25
Musara, Petina
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mgodi, Nyaradzo
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Recruiting
3
3500
RoW
CAB LA, Apretude, CAB LA for PrEP
ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP
HIV Infections
06/28
06/28
CoVPN3008, NCT05168813: Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

Completed
2/3
14232
RoW
Moderna mRNA-1273, Vaccine 3 Dose, Vaccine 2 Dose
COVID-19 Prevention Network, National Institute of Allergy and Infectious Diseases (NIAID), Medical Research Council, South Africa
SARS-CoV-2 Infection, HIV Infections, COVID-19
04/24
04/24
NCT05458765: Project Engage: Oral PrEP Acceptability

Completed
2
330
RoW
emtricitabine/tenofovir alafenamide, Descovy, Emtricitabine / Tenofovir Disoproxil Oral Tablet, Truvada
Eastern Virginia Medical School, CONRAD, FHI 360, United States Agency for International Development (USAID), Gilead Sciences
Acceptability of Health Care, Adherence, Medication
12/23
07/24
MATRIX-003, NCT06163274: Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Rings

Terminated
1
93
US, RoW
Placebo Intravaginal Ring A, Placebo Intravaginal Ring B
University of Pittsburgh, United States Agency for International Development (USAID), Oak Crest Institute of Science
Safety, Acceptability
01/25
01/25
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films

Completed
1
100
US, RoW
Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners
Rohan, Lisa, PhD, United States Agency for International Development (USAID)
Safety, Acceptability, Usability
12/24
12/24
INSIGHT, NCT05746065: A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women

Completed
N/A
3087
RoW
PrEP, Truvada
University of Washington, Bill and Melinda Gates Foundation
HIV Infections
08/23
08/23
NCT04778514: A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

Completed
N/A
30
RoW
Dual Prevention Pill, DPP, PrEP and combined oral contraceptive (COC) as two separate tablets, Truvada, Zinnia F
Population Council, University of Zimbabwe
HIV Infections, Contraception
09/23
09/23
CoVPN3008TB, NCT06585683: Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008

Recruiting
N/A
6000
RoW
Clinical Evaluation at Day 4, Laboratory Evaluation at Day 4, Clinical Evaluation at week 26, Laboratory Evaluation at week 26
COVID-19 Prevention Network, National Institute of Allergy and Infectious Diseases (NIAID), Medical Research Council, South Africa
Tuberculosis
10/25
10/25
Musara, Petina
No trials found

Download Options